Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/1999
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999CN1236367A Benzonaphthyrindines as bronchial therapeutics
11/24/1999CN1236318A Method for treating bronchitis with uridine triphosphates and related compounds
11/24/1999CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use
11/24/1999CN1046718C 6-(2-imidzolinylamino) quinoline compounds useful as alpha-2-adrenoceptor agonists
11/24/1999CN1046712C Process for preparation of leukotriene antagonists
11/24/1999CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
11/23/1999US5990170 Possesses a profile of activity which is similar to, though less potent than .delta.9-thc (tetrahydrocannabinol) with a mimicking of the psychoactive effects; analgesics; side effect reduction; cardiovascular disorders
11/23/1999US5990148 Side effect reductions; antiarthritic agents; nonsteroidal antiinflammatory agents
11/23/1999US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents
11/23/1999US5990130 Therapeutic heterocycles
11/23/1999US5990127 Process for the preparation of 4-(4-(4-(hydroxybiphenyl)-1-piperidinyl)-1-hydroxybutyl)-α,α -dimethylphenylacetic acid and phosphorylated derivatives
11/23/1999US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
11/23/1999US5990103 Treating psoriasis by topical adminstration of pentoxifylline and diltiazem to a patient; a combination of a compound having a phosphodiesterase-inhibiting action, and a compound which reduces the intracellular calcium content
11/23/1999US5990097 Methods of treating asthma with o-desulfated heparin
11/23/1999US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
11/23/1999US5989521 Method for augmenting a decreased level of reduced glutathione in the lung
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058555A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058504A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament
11/18/1999WO1999058503A1 Novel 1,5 and 3-o-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999049856A3 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
11/18/1999WO1999049855A3 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
11/18/1999WO1999028475A3 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
11/18/1999WO1999027098A3 A-33 related antigens and their pharmacological uses
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999DE19821003A1 New dihydro-indazolone derivatives useful as antiasthmatic, antiallergic and neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999DE19821002A1 New indazole derivatives useful as antiasthmatic, antiallergic, neuroprotective agents and for treatment of inflammation and immune disorders
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2331371A1 Water-soluble pro-drugs of propofol
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/17/1999EP0956864A1 Tissue fibrosis inhibitor
11/17/1999EP0956301A2 Il-12 gene expression and delivery systems and uses
11/17/1999EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses
11/17/1999EP0956051A1 Compositions and methods for pulmonary gene delivery
11/17/1999EP0956043A1 Strain selection of pneumococcal surface proteins
11/17/1999EP0956014A1 Method for increasing the solubility of clemastine and pharmaceutical compositions prepared therefrom
11/17/1999EP0955808A1 Human g-protein coupled receptor
11/17/1999CN1235609A Immunostimulatory nucleic acid molecules
11/17/1999CN1235608A Alkylated reapamycin derivatives
11/17/1999CN1235545A Composition, for treatment of asthma, containing loratadine and decongestant
11/17/1999CN1235046A External-use medicine for pharyngitis
11/17/1999CN1235043A Powder for relieving cough and asthma
11/17/1999CN1234976A Method for extracting sulphur containing part from garlic and preparation of oil containing sulphur part
11/16/1999US5985937 Leukotriene mediated disease in humans for enzyme inhibitors
11/16/1999US5985928 Bioactive bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof
11/16/1999US5985917 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985881 Treatment and prevention of respiratory disorders, inflammatory eye diseases, inflammatory skin diseases, intestinal disorders, other inflammatory diseases
11/16/1999US5985880 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
11/16/1999US5985866 Use of serotonin antagonists for treating fibromyalgia
11/16/1999US5985852 Composition for inhibiting binding between a first cell having a p- or l-selectin and a second cell having a ligand for the selectin, comprising a sheet of lipids
11/16/1999US5985851 Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
11/16/1999US5985850 Comprising a therapeutically effective amount of an agent to treat a disease or condition involving underperfused tissue and pathological tissue in humans and a form of hyaluronic acid as transport agent
11/16/1999US5985849 Phosphate compounds and their use as medicaments
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999CA1340824C Neurokinin a antagonists
11/11/1999WO1999057320A1 Antisense modulation of cd40 expression
11/11/1999WO1999057288A1 Endothelin-converting-enzyme like protein
11/11/1999WO1999057133A2 Inhibitors of nf-kb activation
11/11/1999WO1999057118A1 Novel n-oxides
11/11/1999WO1999057115A1 Novel benzimidazoles and benzoxazoles
11/11/1999WO1999057114A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999056752A1 sPLA2 INHIBITOR ESTER
11/11/1999WO1999047132A3 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
11/11/1999WO1999045916A3 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
11/11/1999WO1999041402A3 Targeting of genetic vaccine vectors
11/11/1999WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999WO1999040073A3 Tryptase inhibitors
11/11/1999CA2331037A1 Novel benzimidazoles and benzoxazoles
11/11/1999CA2331036A1 Spla2 inhibitor ester
11/11/1999CA2330738A1 Novel n-oxides of benzonaphthyridines
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328483A1 Inhibitors of nf-kb activation
11/11/1999CA2271837A1 1,2,5,-trisubstituted 1,2,-dihydroindazol-3-ones having anti-asthmatic, anti-allergic, anti-inflammatory, immunomodulating and neuroprotective action, process for their preparation and their use as medicaments
11/11/1999CA2248963A1 Novel compounds
11/10/1999EP0955295A1 Therapeutically active levorotatory and dextrorotatory 1-((4-chlorophenyl)phenylmethyl) piperazines
11/10/1999EP0955060A1 Remedies for acute pulmonary injuries due to indirect causes containing anti-il-8 antibody as the active ingredient
11/10/1999EP0954535A1 Antibodies that bind to the nidogen-binding domain of laminin, their production and use
11/10/1999EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999EP0954338A2 Cationic amphiphile/dna complexes
11/10/1999EP0954320A1 Inositol polyphosphate derivatives and methods of using same
11/10/1999EP0954292A1 Pharmaceutical formulations with delayed drug release
11/10/1999EP0863873B1 Indole carbamates as leukotriene antagonists
11/10/1999CN1234806A G protein-coupled receptor antagonists
11/10/1999CN1234800A Naphthyridine derivatives
11/10/1999CN1234396A Process for alkylation of hindered sulfamide
11/10/1999CN1234229A Apparatus for treatment of immunomediated inflammatory disorders
11/10/1999CN1046274C Isoxazoline compounds as antinflammatory agents
11/09/1999US5981780 In vivo calcium transport as well as bone calcium mobilization activity, treatment of osteoporosis, possible use in the treatment of cancerous diseases
11/09/1999US5981762 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors
11/09/1999US5981755 Tachykinin antagonists
11/09/1999US5981540 Selective delta opioid agonists and antagonists; useful as analgesics and in treating general neurologic disorders
11/09/1999US5981539 Piperidine compounds as calcium channel blockers
1 ... 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 ... 878